Bridging the gap between academic IP and technology commercialization.


KensaGroup creates, launches and develops leading edge intellectual property platforms into successful technology-based businesses. KensaGroup uses a proprietary approach to identify and evaluate promising discoveries from universities and corporate research initiatives, then creates the necessary scientific, institutional, and financial bridges that lead from initial discovery to successful commercialization.

Latest News

09.06.18 - Collaboration to apply causal artificial intelligence and clinical trial data to identify factors that drive treatment response in patients with metastatic colorectal cancer...more

08.16.18 - Via CEO presents at 2018 Energy Impact Partners Roundtable and Iberdrola's Innoday...more

06.11.18 - 2018 R&D teams of the year: Grainful...more

05.10.18 - Mayo Clinic researchers study sterilization methods and materials related to vascular heart disease (VHD) treatment...more

04.23.18 - Grainful is redefining the most important meal of the day ...more

03.29.18 - GNS Healthcare using AI and longitudinal data to better multiple myeloma...more


KensaGroup, LLC

2415 N. Triphammer Road

Ithaca, NY 14850

phone: 1.607.330.2307

Fax: 1.607.330.2319